Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.38
TRNX's Cash to Debt is ranked lower than
79% of the 318 Companies
in the Global Medical Devices industry.

( Industry Median: 2.38 vs. TRNX: 0.38 )
Ranked among companies with meaningful Cash to Debt only.
TRNX' s 10-Year Cash to Debt Range
Min: 0.18  Med: 0.85 Max: N/A
Current: 0.38
Equity to Asset 0.70
TRNX's Equity to Asset is ranked higher than
57% of the 280 Companies
in the Global Medical Devices industry.

( Industry Median: 0.66 vs. TRNX: 0.70 )
Ranked among companies with meaningful Equity to Asset only.
TRNX' s 10-Year Equity to Asset Range
Min: 0.42  Med: 0.74 Max: 0.79
Current: 0.7
0.42
0.79
F-Score: 3
Z-Score: 3.72
M-Score: -2.57
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating margin (%) -5.84
TRNX's Operating margin (%) is ranked lower than
60% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 2.94 vs. TRNX: -5.84 )
Ranked among companies with meaningful Operating margin (%) only.
TRNX' s 10-Year Operating margin (%) Range
Min: -16.1  Med: -7.74 Max: -2.74
Current: -5.84
-16.1
-2.74
Net-margin (%) -8.53
TRNX's Net-margin (%) is ranked lower than
61% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 1.99 vs. TRNX: -8.53 )
Ranked among companies with meaningful Net-margin (%) only.
TRNX' s 10-Year Net-margin (%) Range
Min: -27.11  Med: -11.71 Max: -7.84
Current: -8.53
-27.11
-7.84
ROE (%) -5.99
TRNX's ROE (%) is ranked lower than
60% of the 288 Companies
in the Global Medical Devices industry.

( Industry Median: 2.94 vs. TRNX: -5.99 )
Ranked among companies with meaningful ROE (%) only.
TRNX' s 10-Year ROE (%) Range
Min: -24.23  Med: -8.32 Max: -5.19
Current: -5.99
-24.23
-5.19
ROA (%) -4.35
TRNX's ROA (%) is ranked lower than
56% of the 320 Companies
in the Global Medical Devices industry.

( Industry Median: -0.33 vs. TRNX: -4.35 )
Ranked among companies with meaningful ROA (%) only.
TRNX' s 10-Year ROA (%) Range
Min: -10.97  Med: -5.72 Max: -3.73
Current: -4.35
-10.97
-3.73
ROC (Joel Greenblatt) (%) -14.37
TRNX's ROC (Joel Greenblatt) (%) is ranked lower than
58% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 3.55 vs. TRNX: -14.37 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
TRNX' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -84.48  Med: -19.83 Max: -15.68
Current: -14.37
-84.48
-15.68
Revenue Growth (3Y)(%) 1.10
TRNX's Revenue Growth (3Y)(%) is ranked lower than
59% of the 193 Companies
in the Global Medical Devices industry.

( Industry Median: 3.00 vs. TRNX: 1.10 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
TRNX' s 10-Year Revenue Growth (3Y)(%) Range
Min: -6.1  Med: -4.15 Max: 1.1
Current: 1.1
-6.1
1.1
EPS Growth (3Y)(%) -9.10
TRNX's EPS Growth (3Y)(%) is ranked lower than
58% of the 171 Companies
in the Global Medical Devices industry.

( Industry Median: -1.60 vs. TRNX: -9.10 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
TRNX' s 10-Year EPS Growth (3Y)(%) Range
Min: -38.1  Med: -18.70 Max: -9.1
Current: -9.1
-38.1
-9.1
» TRNX's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2014

TRNX Guru Trades in Q1 2014

Steven Cohen 176,057 sh (New)
» More
Q3 2014

TRNX Guru Trades in Q3 2014

Steven Cohen 269,700 sh (New)
» More
Q4 2014

TRNX Guru Trades in Q4 2014

Steven Cohen 199,600 sh (-25.99%)
» More
Q1 2015

TRNX Guru Trades in Q1 2015

Steven Cohen 190,400 sh (-4.61%)
» More
» Details

Insider Trades

Latest Guru Trades with TRNX

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 2.71
TRNX's P/B is ranked higher than
56% of the 288 Companies
in the Global Medical Devices industry.

( Industry Median: 3.18 vs. TRNX: 2.71 )
Ranked among companies with meaningful P/B only.
TRNX' s 10-Year P/B Range
Min: 1.47  Med: 1.96 Max: 2.91
Current: 2.71
1.47
2.91
P/S 3.54
TRNX's P/S is ranked lower than
55% of the 289 Companies
in the Global Medical Devices industry.

( Industry Median: 3.11 vs. TRNX: 3.54 )
Ranked among companies with meaningful P/S only.
TRNX' s 10-Year P/S Range
Min: 2.22  Med: 3.00 Max: 4.04
Current: 3.54
2.22
4.04
Current Ratio 2.33
TRNX's Current Ratio is ranked lower than
55% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 2.62 vs. TRNX: 2.33 )
Ranked among companies with meaningful Current Ratio only.
TRNX' s 10-Year Current Ratio Range
Min: 2.19  Med: 2.70 Max: 3.29
Current: 2.33
2.19
3.29
Quick Ratio 1.44
TRNX's Quick Ratio is ranked lower than
65% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 2.02 vs. TRNX: 1.44 )
Ranked among companies with meaningful Quick Ratio only.
TRNX' s 10-Year Quick Ratio Range
Min: 1.18  Med: 1.63 Max: 1.99
Current: 1.44
1.18
1.99
Days Inventory 408.30
TRNX's Days Inventory is ranked lower than
94% of the 280 Companies
in the Global Medical Devices industry.

( Industry Median: 130.93 vs. TRNX: 408.30 )
Ranked among companies with meaningful Days Inventory only.
TRNX' s 10-Year Days Inventory Range
Min: 367.89  Med: 383.88 Max: 428.02
Current: 408.3
367.89
428.02
Days Sales Outstanding 78.33
TRNX's Days Sales Outstanding is ranked lower than
59% of the 274 Companies
in the Global Medical Devices industry.

( Industry Median: 68.45 vs. TRNX: 78.33 )
Ranked among companies with meaningful Days Sales Outstanding only.
TRNX' s 10-Year Days Sales Outstanding Range
Min: 64.15  Med: 68.64 Max: 83.52
Current: 78.33
64.15
83.52

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 52.96
TRNX's Price/Net Current Asset Value is ranked lower than
94% of the 190 Companies
in the Global Medical Devices industry.

( Industry Median: 6.26 vs. TRNX: 52.96 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
TRNX' s 10-Year Price/Net Current Asset Value Range
Min: 7.64  Med: 17.73 Max: 55.79
Current: 52.96
7.64
55.79
Price/Tangible Book 9.68
TRNX's Price/Tangible Book is ranked lower than
77% of the 262 Companies
in the Global Medical Devices industry.

( Industry Median: 4.40 vs. TRNX: 9.68 )
Ranked among companies with meaningful Price/Tangible Book only.
TRNX' s 10-Year Price/Tangible Book Range
Min: 4.08  Med: 5.96 Max: 11.71
Current: 9.68
4.08
11.71
Price/Projected FCF 4.43
TRNX's Price/Projected FCF is ranked lower than
72% of the 101 Companies
in the Global Medical Devices industry.

( Industry Median: 2.13 vs. TRNX: 4.43 )
Ranked among companies with meaningful Price/Projected FCF only.
TRNX' s 10-Year Price/Projected FCF Range
Min: 4.02  Med: 4.67 Max: 5.61
Current: 4.43
4.02
5.61
Price/Median PS Value 1.19
TRNX's Price/Median PS Value is ranked lower than
56% of the 243 Companies
in the Global Medical Devices industry.

( Industry Median: 1.11 vs. TRNX: 1.19 )
Ranked among companies with meaningful Price/Median PS Value only.
TRNX' s 10-Year Price/Median PS Value Range
Min: 0.8  Med: 0.95 Max: 1.26
Current: 1.19
0.8
1.26
Earnings Yield (Greenblatt) (%) -1.60
TRNX's Earnings Yield (Greenblatt) (%) is ranked lower than
57% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 0.80 vs. TRNX: -1.60 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
TRNX' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: -2  Med: 0.00 Max: 0
Current: -1.6
-2
0

Business Description

Industry: Medical Devices » Medical Devices
Compare: » details
Traded in other countries:T98.Germany,
Tornier NV is a medical device company founded in the year 1940. The Company, along with its subsidiaries, provides solutions to surgeons that treat musculoskeletal injuries and disorders of the shoulder, elbow, wrist, hand, ankle and foot, which refers to as "extremity joints." It sells to these surgeons a joint replacement, trauma, sports medicine and biologic products to treat extremity joints. In foreign markets, the Company also offers joint replacement products for the hip and knee. Its customers are surgeon specialists focused on extremity injuries and disorders, along with general surgeons and podiatrists that perform extremities-related surgical procedures. The Company competes with orthopaedic manufacturers, such as DePuy Orthopaedics, Inc., a Johnson & Johnson subsidiary, Biomet, Inc., Zimmer Corporation and Stryker Corporation, and established mid-sized orthopaedic manufacturers, such as Arthrex, Inc., Wright Medical Group, Inc., Exactech, Inc., Integra LifeSciences Corporation and ArthroCare Corporation. The Company is subject to regulation by the U.S. Food and Drug Administration, other federal governmental agencies and state agencies in the United States and similar foreign governmental authorities in countries located outside the United States.
» More Articles for TRNX

Headlines

Articles On GuruFocus.com
No related article found.

More From Other Websites
Wright Medical Q2 Loss Wider than Expected, Sales Up Y/Y - Analyst Blog Jul 30 2015
Tornier to Report Second Quarter 2015 Financial Results on August 5, 2015 Jul 29 2015
Tornier to Report Second Quarter 2015 Financial Results on August 5, 2015 Jul 29 2015
TORNIER N.V. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to... Jun 19 2015
Wright Medical-Tornier Merger Wins Shareholders' Approval - Analyst Blog Jun 19 2015
Wright Medical and Tornier Shareholders Approve All Proposals Related to Merger Jun 18 2015
Wright Medical and Tornier Shareholders Approve All Proposals Related to Merger Jun 18 2015
Wright Medical and Tornier Shareholders Approve All Proposals Related to Merger Jun 18 2015
TORNIER N.V. Files SEC form 8-K, Other Events May 29 2015
Coverage initiated on Tornier by Northland Capital May 14 2015
Wright and Tornier Shareholder Meetings Scheduled for June 18, 2015 May 14 2015
TORNIER N.V. Financials May 13 2015
Wright and Tornier Shareholder Meetings Scheduled for June 18, 2015 May 07 2015
Tornier reports 1Q loss May 05 2015
Tornier reports 1Q loss May 05 2015
Tornier Reports First Quarter 2015 Results and Provides Updated 2015 Outlook May 05 2015
TORNIER N.V. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... May 05 2015
Tornier Reports First Quarter 2015 Results and Provides Updated 2015 Outlook May 05 2015
Q1 2015 Tornier NV Earnings Release - After Market Close May 05 2015
Wright Medical Q1 Loss Wider than Expected, Sales Up Y/Y - Analyst Blog Apr 30 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK